Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years (Q28344317)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years	scientific article

Statements

scholarly article

0 references

Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years (English)

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

Thomas E. Starzl

8

object named as

T E Starzl

0 references

Anthony J. Demetris

2

object named as

A J Demetris

0 references

John Julian Fung

9

object named as

J J Fung

0 references

author name string

A Jain

1

0 references

R Kashyap

3

0 references

K Blakomer

4

0 references

K Ruppert

5

0 references

A Khan

6

0 references

S Rohal

7

0 references

language of work or name

0 references

publication date

July 2001

0 references

Liver Transplantation

0 references

7

0 references

623-30

0 references

7

0 references

Liver transplantation with use of cyclosporin a and prednisone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

20 March 2017

Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Chronic rejection of the liver allograft.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Chronic allograft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Effect of donor age and sex on the outcome of liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Randomised trialomania? The multicentre liver transplant trials of tacrolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Pathologic analysis of liver transplantation for primary biliary cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Patterns of graft rejection following liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Early trials with FK 506 as primary treatment in liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

29 September 2017

Recurrence of autoimmune hepatitis after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Allograft rejection after liver transplantation for autoimmune liver diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Causes of graft loss following liver transplantation for chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Vanishing bile-duct syndrome following liver transplantation--is it reversible?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

FK 506 used as rescue therapy for human liver allograft recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Liver, kidney, and thoracic organ transplantation under FK 506.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

2 June 2018

Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

27 November 2018

Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

27 November 2018

Chronic liver allograft rejection: a National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. National Institute of Diabetes and D

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

27 November 2018

Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

27 November 2018

A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

27 November 2018

Bile duct injury as a part of diagnostic criteria for liver allograft rejection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2965463

27 November 2018

INCREASED INCIDENCE OF CHRONIC REJECTION IN ADULT PATIENTS TRANSPLANTED FOR AUTOIMMUNE HEPATITIS: ASSESSMENT OF RISK FACTORS1

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noncompliance in organ transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for the histopathological classification of liver allograft rejection and their clinical relevance

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect"

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex mismatch as a risk factor for chronic rejection of liver allografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noncompliance after pediatric liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence of primary sclerosing cholangitis following liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11460230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28344317&oldid=1956877478"